References
- Lyra PPR, Campos GS, Bandeira ID, Sardi SI, Costa LFDM, Santos FR, Ribeiro C, Jardim A, Santiago A, de Oliveira P, et al. Congenital Chikungunya virus infection after an outbreak in Salvador, Bahia, Brazil. Am J Perinatol Rep. 2016;6(03):299–300. doi:https://doi.org/10.1055/s-0036-1587323.
- Siddique R, Liu Y, Nabi G, Sajjad W, Xue M, Khan S. Zika Virus potentiates the development of neurological defects and microcephaly: challenges and control strategies. Front Neurol. 2019;10:(April):1–9. doi:https://doi.org/10.3389/fneur.2019.00319.
- Musso D, Gluber DJ. Zika Virus. Clin Microbiol Reviews. 2016;29:487–524.
- Carvalho A, Brites C, Mochida G, Ventura P, Fernandes A, Lage ML, Taguchi T, Brandi I, Silva A, Franceschi G, et al. Clinical and neurodevelopmental features in children with cerebral palsy and probable congenital Zika. Brain Dev. 2019;41(7):587-594. doi: https://doi.org/10.1016/j.braindev.2019.03.005.
- Singhi P, Ray M. Botulinum toxin in children with cerebral palsy. Indian J Pediatr. 2004;71(12):1087–91. doi:https://doi.org/10.1007/BF02829820.
- Hsiung GYR, Das SK, Ranawaya R, Lafontaine AL, Suchowersky O. Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period. Mov Disord. 2002;17(6):1288–93. doi:https://doi.org/10.1002/mds.10252.
- Sales HF, Cerqueira C, Vaz D, Medeiros-Rios D, Armani-Franceschi G, Lucena PH, Sternberg C, Nóbrega AC, Luz C, Fonseca D, et al. The impact of botulinum toxin type A in the treatment of drooling in children with cerebral palsy secondary to Congenital Zika Syndrome: an observational study. Neurol Res. 2021;43(1):54-60. doi: https://doi.org/10.1080/01616412.2020.1820698.
- Bandeira ID, Jagersbacher JG, Barretto TL, Santos CV, Lucena R. Botulinum toxin type A in the treatment of facial myotonia in Schwartz-Jampel syndrome. Muscle and Nerve. 2017;56:2.
- Strobl W, Theologis T, Brunner R, Kocer S, Viehweger E, Pascual-Pascual I, Placzek R.. Best clinical practice in botulinum toxin treatment for children with cerebral palsy. Toxins (Basel). 2015;7(5):1629–48. doi:https://doi.org/10.3390/toxins7051629.
- Chan JF, Yip CC, Tsang JO, Tee KM, Cai JP, Chik KK, Zhu Z, Chan CC, Choi GK, Sridhar S, et al. Differential cell line susceptibility to the emerging Zika virus: implications for disease pathogenesis, non-vector-borne human transmission and animal reservoirs. Emerg Microbes Infect. 2016;5(8):e93. doi: https://doi.org/10.1038/emi.2016.99.
- Chimelli L, Melo ASO, Avvad E, Wiley CA, Camacho AHS, Lopes VS, Machado HN, Andrade CV, Dock DCA, Moreira ME, et al. The spectrum of neuropathological changes associated with congenital Zika virus infection. Acta Neuropathol. 2017;133(6):983–99. doi:https://doi.org/10.1007/s00401-017-1699-5.
- Franca GVA, Schuler-Faccini L, Oliveira WK, Henriques CMP, Carmo EH, Pedi VD, Nunes ML, Castro MC, Serruya S, Silveira MF, et al. Congenital Zika virus syndrome in Brazil: a case series of the first 1501 livebirths with complete investigation. Lancet (London, England). 2016 Aug;388(10047):891–97. doi:https://doi.org/10.1016/S0140-6736(16)30902-3.
- World Health Organization: international classification of functioning, disability and health (ICF). World Heal Organ. 2001.
- Palisano R, Rosenbaum P, Walter S, Russel D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997;39:214–23. doi:https://doi.org/10.1111/j.1469-8749.1997.tb07414.x.
- Hiratuka E, Matsukura TS, Pfeifer LI. Adaptação transcultural para o Brasil do sistema de classificação da função motora grossa (GMFCS). Rev Bras Fisioter. 2010;14(6):537–44. doi:https://doi.org/10.1590/S1413-35552010000600013.
- Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987;67(2):206–07. doi:https://doi.org/10.1093/ptj/67.2.206.
- Texeira LF, Olney SJ, Brouwer B. Mecanismos e Medidas de Espasticidade.pdf. Rev Fisioter. 1998;5:4–19.
- Andrade AC, Magnavita GM, Allegro JVBN, Neto CEBP, Lucena RDCS, Fregni F. Feasibility of transcranial direct current stimulation use in children aged 5 to 12 years. J Child Neurol. 2014 Oct;29(10):1360–65. doi:https://doi.org/10.1177/0883073813503710.
- Bandeira ID, Guimarães RS, Jagersbacher JG, Barretto TL, de Jesus-Silva JR, Santos SN, Argollo N, Lucena R. Transcranial Direct Current Stimulation in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD): A Pilot Study. J Child Neurol. 2016 Jun;31(7):918–24. doi:https://doi.org/10.1177/0883073816630083
- A Ventura P, C Lage ML, L de Carvalho A, S Fernandes A, B Taguchi T, Nascimento-Carvalho CM. Early Gross Motor Development Among Brazilian Children with Microcephaly Born Right After Zika Virus Infection Outbreak. J Dev Behav Pediatr. 2020;41(2):134-140. doi: https://doi.org/10.1097/DBP.0000000000000722.
- Pin TW, Elmasry J, Lewis J. Efficacy of botulinum toxin A in children with cerebral palsy in gross motor function classification system levels IV and V: a systematic review. Dev Med Child Neurol. 2012;55(4):304–13. doi: https://doi.org/10.1111/j.1469-8749.2012.04438.x.
- Pingel J, Hultborn H, Näslund-Koch L, Jensen DB, Wienecke J, Nielsen JB. Muscle disuse caused by botulinum toxin injection leads to increased central gain of the stretch reflex in the rat. J Neurophysiol. 2017;118(4):1962–69. doi:https://doi.org/10.1152/jn.00276.2017.
- Guyot P, Kalyvas C, Mamane C, Danchenko N. Botulinum Toxins Type A (Bont-A) in the management of lower limb spasticity in children: a systematic literature review and Bayesian network meta-analysis. J Child Neurol. 2019;34(7):371–81. doi:https://doi.org/10.1177/0883073819830579.
- Bandeira ID, Mendoza J. Medical education and leadership: a call to action for Brazil's mental health system. Int J Med Educ. 2018 Jun 22;9:170-172.doi:https://doi.org/10.5116/ijme.5b1b.b0a2
- Dorf SR, Caldas CACT, Chueire RHMF, Carvalho JH, Brito JAF, Maciel SC, Sarmento EM, Ramos AM. Uso prático da AbobotulinumtoxinA no tratamento de espasticidade em crianças com paralisia cerebral. Acta Fisiátrica. 2018;24(3):160–64.doi:https://doi.org/10.5935/0104-7795.20170030.
- Matthews D, Camba GC, Pascual-Pascual I, Tilton AH, Gormley M, Mahmood A, Picaut P, Snyder D, Delgado MR. Poster 485 safety and tolerability of abobotulinumtoxinA (dysport) in children (2-17 years) with lower limb spasticity due to cerebral palsy: a pooled analysis of 8 clinical trials. Pm&R. 2016;8(9):S318. doi:https://doi.org/10.1016/j.pmrj.2016.07.403.
- Keeratisiroj O, Thawinchai N, Buntragulpoontawee M, Siritaratiwat W. Derivation of an ambulatory prognostic score chart for Thai children with cerebral palsy aged 2 to 18. J Med Assoc Thail. 2016;99:1298–305.
- Vles GF, de Louw AJA, Speth LA, van Rhijn LW, Janssen-Potten YJM, Hendriksen JG, Vles JSH. Visual analogue scale to score the effects of botulinum toxin A treatment in children with cerebral palsy in daily clinical practice. Eur J Paediatr Neurol. 2008;12(3):231–38. doi:https://doi.org/10.1016/j.ejpn.2007.08.002.
- Manzano FS, Granero LM, Masiero D, Dos SMTBR. Treatment of muscle spasticity in patients with cerebral palsy using BTX-A: a pilot study. Spec Care Dent. 2004;24(4):235–39. doi:https://doi.org/10.1111/j.1754-4505.2004.tb01699.x.
- Fragala M, O’neil M, Russo K, Dumas H. Impairment, disability, and satisfaction outcomes after lower-extremity botulinum toxin a injections for children with cerebral palsy. Pediatr Phys Ther. 2002;14:132–44.
- Gooch JL, Sandell TV. Botulinum toxin for spasticity and athetosis in children with cerebral palsy. Arch Phys Med Rehabil. 1996;77(5):508–11. doi:https://doi.org/10.1016/S0003-9993(96)90042-8.
- Lundy CT, Doherty GM, Fairhurst CB. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy. Dev Med Child Neurol. 2009;51(9):705–10. doi:https://doi.org/10.1111/j.1469-8749.2009.03315.x.
- Fattal-Valevski A, Giladi N, Domanievitz D, Zuk L, Masterman R, Harel S, Wientroub S, Hayek S. Parameters for predicting favorable responses to botulinum toxin in children with cerebral palsy. J Child Neurol. 2002;17(4):272–77. doi:https://doi.org/10.1177/088307380201700407.
- Bandeira ID, Lins-Silva DH, Barouh JL, Faria-Guimarães D, Dorea-Bandeira I, Souza LS, Alves GS, Brunoni AR, Nitsche M, Fregni F, et al. Neuroplasticity and non-invasive brain stimulation in the developing brain. Prog Brain Res. 2021;264:57-89. doi: https://doi.org/10.1016/bs.pbr.2021.04.003.
- Barretto TL, Bandeira ID, Jagersbacher JG, Barretto BL, de Oliveira E Torres ÂFS, Peña N, Miranda JGV, Lucena R. Transcranial direct current stimulation in the treatment of cerebellar ataxia: A two-phase, double-blind, auto-matched, pilot study. Clin Neurol Neurosurg. 2019 Jul;182:123-129.doi:https://doi.org/10.1016/j.clineuro.2019.05.009
- Rios DM, Correia Rios M, Bandeira ID, Queiros Campbell F, de Carvalho Vaz D, Lucena R. Impact of Transcranial Direct Current Stimulation on Reading Skills of Children and Adolescents With Dyslexia. Child Neurol Open. 2018 Oct 4;5:2329048X18798255. doi: https://doi.org/10.1177/2329048X18798255.
- Guimarães RSQ, Bandeira ID, Barretto BL, Barretto TL, Wanke T, Alves COC. The effects of transcranial direct current stimulation on attention and inhibitory control of children and adolescents with attention-deficit/hyperactivity disorder (ADHD): study protocol for a randomized, sham-controlled, triple-blind, cross-over trial. Medicine (Baltimore). 2021 Feb;100(8):e24283. doi:https://doi.org/10.1097/MD.0000000000024283.
- León Ruiz M, Rodríguez Sarasa ML, Sanjuán Rodríguez L, Benito-León J, García-Albea Ristol E, Arce Arce S. Current evidence on transcranial magnetic stimulation and its potential usefulness in post-stroke neurorehabilitation: opening new doors to the treatment of cerebrovascular disease. Neurologia. 2018 Sep;33(7):459–72. doi:https://doi.org/10.1016/j.nrl.2016.03.008.
- Barreto TM, Bento MN, Barreto TM, Jagersbacher JG, Jones NS, Lucena R, Bandeira ID. Prevalence of depression, anxiety, and substance-related disorders in parents of children with cerebral palsy: a systematic review. Dev Med Child Neurol. 2020;62(2):163–68. doi:https://doi.org/10.1111/dmcn.14321.
- Silva-Moraes MH, Bispo-Torres AC, Barouh JL, Lucena PH, Armani-Franceschi G, Dorea-Bandeira I, Vieira F, Miranda-Scippa Â, Quarantini LC, Lucena R, Bandeira ID. Suicidal behavior in individuals with amyotrophic lateral sclerosis: A systematic review. J Affect Disord. 2020;277:688-696. doi: https://doi.org/10.1016/j.jad.2020.08.066.
- Bleck EE. Locomotor prognosis in cerebral palsy. Dev Med Child Neurol. 1975;17(1):18–25. doi:https://doi.org/10.1111/j.1469-8749.1975.tb04952.x.
- Molnar G, Gordon S. Cerebral palsy: predictive value of selected clinical signs for early prognostication of motor function. Arch Phys Med Rehabil. 1976;57(4):153–58.
- Hu B, Zhang X, Mu J, Wu M, Wang Y. Spasticity assessment based on the Hilbert-Huang transform marginal spectrum entropy and the root mean square of surface electromyography signals: a preliminary study. Biomed Eng Online. 2018 Feb;17(1):27. doi:https://doi.org/10.1186/s12938-018-0460-1.
- Mutlu A, Livanelioglu A, Gunel MK. Reliability of Ashworth and modified Ashworth scales in children with spastic cerebral palsy. BMC Musculoskelet Disord. 2008;9(1):1–8. doi:https://doi.org/10.1186/1471-2474-9-44.
- Ka Ling Yam W, So Mei Leung M, Alice Ho Miu P. Interrater reliability of modified Ashworth scale and modified Tardieu scale in children with spastic cerebral palsy from the departments of paediatrics and adolescent medicine (Dr Yam). J Child Neurol. 2006;21(12):1031–35. doi:https://doi.org/10.1177/7010.2006.00222.